When Colton Matter was 9 years old, an accident with a scooter revealed an unanticipated diagnosis: hypo-diploid acute lymphoblastic leukemia. Four years later, following multiple relapses and two bone marrow transplants, Colton was eligible for the CAR-T cell trial at CHOP. Colton is now more than two years cancer free!
Nick Wilkins was four years old when a routine doctor appointment led to an unwanted diagnosis: Acute Lymphoblastic Leukemia. When Nick relapsed for the second time following years of standard chemotherapy and a bone marrow transplant, he was entered into the CAR-T cell therapy clinical trial at CHOP as Patient #15. Today, Nick is healthy, attending college, and 4.5 years cancer free!
Jeremiah "L.J." Graham was diagnosed with Acute Lymphoblastic Leukemia when he was five years old. Following multiple relapses, L.J.'s remaining treatment options were few. In March 2015, L.J. was accepted into the Phase I CAR-T cell clinical trial at Children's Hospital of Philadelphia (CHOP). Two and a half years later, L.J. remains cancer free!
At age eleven, Ryan Durant was diagnosed with Acute Lymphoblastic Leukemia. When Ryan's cancer proved to be resistant to standard chemotherapy treatments, his doctors recommend the CAR-T cell trial at Duke University. Ryan received his T-cells in January 2016 and has since remained cancer free!
At age seven, Emily Hunt was diagnosed with B-cell Acute Lymphoblastic Leukemia. When Emily's cancer returned following years of standard chemotherapy treatments, her parents sought out the CAR-T cell therapy clinical trial at Children's Hospital of Philadelphia. Emily received her T-cells in June 2014 and remains happy, healthy and 3 years cancer free.
At age five, Tori was diagnosed with Acute Lymphoblastic Leukemia. Following years of standard treatments, Tori became the 10th patient to receive her genetically engineered T-cells in the CAR T-cell trial at CHOP. Tori is now healthy and celebrating 4 years cancer free!